Monday, August 25, 2008
On August 25, 2008, Palisade Concentrated Equity Partnership II, LP ("PCEPII"), a $140 million private equity fund managed by Palisade Capital Management, LLC, committed to invest $3 million in Caliber Therapeutics, Inc. ("Caliber"). Caliber is a provider of a potentially game-changing drug-eluding balloon technology for vascular applications. PCEPII committed to two separate tranches and invested $1.35 million in the first tranche of the $9 million Series A financing round. These funds will be used to secure and develop intellectual property, pay joint venture development costs, and prepare for clinical studies.
View all Latest News & Insight